Results 121 to 130 of about 5,784 (166)

Induction Systemic Therapy Followed by Response-Adapted Consolidative Radiation in Locally Advanced Non-Melanoma Skin Cancer: A Retrospective Case Series. [PDF]

Curr Oncol
Vaidya P, Azenkot T, Bliamptis J, Victor MT, Dornisch A, Chang J, Sanghvi P, Guo T, Park SJ.   +8 more
europepmc   +1 more source

Successful Alternative Administration of Sonidegib in a Patient with Gorlin-Goltz Syndrome and Dysphagia: A Case Report. [PDF]

Case Rep Dermatol
Bender A, Krönig L.
europepmc   +1 more source

Metastatic Basal Cell Carcinoma With Unusual Molecular Genetics Findings. [PDF]

Clin Case Rep
Al-Hail N, Al-Abdulla M, Rizvi S, Al-Hayki N.   +3 more
europepmc   +1 more source

Establishing FDA-approved oncology drugs as GPR176 inhibitor through homology modelling, molecular docking, MMGBSA, DFT, and molecular dynamics simulation. [PDF]

Sci Rep
Ishabiyi FO, Umar HI, Dutta T, Onyinye OC, Damola OD, Budagova L, Temesgen D, Bourhia M, Bello RO, Alyami EM, Alsolami M, Almohammed OA.   +11 more
europepmc   +1 more source

Targeting SPP1-CD44-Hedgehog Axis Elicits Therapeutic Effects in Hepatocellular Carcinoma by Suppressing Intratumoral Fibrosis. [PDF]

Cancer Sci
Nara A, Shimada S, Akiyama Y, Hatano M, Chino Y, Miyazawa S, Tamura H, Asano D, Ishikawa Y, Ueda H, Watanabe S, Katsuta E, Akahoshi K, Ohashi K, Tanabe M, Ban D, Tanaka S.   +16 more
europepmc   +1 more source

Neoadjuvant Hedgehog Inhibitors for Locally Advanced Basal Cell Carcinoma: Insights from Two Real-world Cases. [PDF]

Acta Derm Venereol
Antonetti P, Lupi E, Tucceri Cimini I, Esposito M, Fargnoli MC.   +4 more
europepmc   +1 more source

Advances in Targeted and Immunotherapy for High-Risk Cutaneous Malignancies. [PDF]

Oncol Res
Petty AJ, Emge DA, Cardones AR.
europepmc   +1 more source